Since June last year, MeDomino has held several sessions of the Life Sciences Omnichannel Digital Precision Marketing Seminar in Shanghai.
Last week, the seminar finally arrived in Beijing. On July 19, 2024, we gathered with more than ten senior executives from life sciences companies at Beijing China World.
MeDomino founder and CEO Lu Wenqing
MeDomino Partner Guo Wenping
This was actually our first attempt at a dinner-format seminar. We hoped to provide everyone with a more relaxed discussion atmosphere. We specially invited the Vice President of Digital Innovation at a multinational pharmaceutical company and the Deputy Director of Medical Affairs at another multinational pharmaceutical company to share implementation experience in omnichannel precision marketing and ideas on how AIGC can empower medical affairs.
Vice President of Digital Innovation at a multinational pharmaceutical company
Deputy Director of Medical Affairs at a multinational pharmaceutical company
Many guests emphasized in their sharing that digital transformation must be closely aligned with business needs. This matches what we have always emphasized: do high-business-value work first. The first group of pharmaceutical companies that launched MeDomino AIGC have already achieved real cost reduction and efficiency gains.
For one pharmaceutical medical affairs department alone, new content generation efficiency has increased by nearly 60% or more. High-frequency use of one-click summarization and intelligent Q&A has improved content understanding efficiency many times over.
However, efficient content understanding and rapid generation are not the end point of precision marketing. They are tools in the marketing process. The next step is personalized content distribution and engagement for customers. Yet content generation in the life sciences industry is already highly complex, with high labor and time costs, let alone generating personalized content precise enough to match different customer belief levels.
To shift the perspective, MeDomino's original intention in AI innovation is to make the impossible possible. Now this problem can be solved with AI:
1. When MeDomino's AIGC capabilities are applied to customer insights, integrated analysis of internal and external data can quickly help pharma and medtech companies identify customers' belief levels.
2. AI then manages all existing enterprise content, builds an enterprise-level intelligent knowledge base, matches customer beliefs with enterprise content, and rapidly generates large volumes of personalized content resources.
3. Instructions are then sent to frontline colleagues through MeDomino ACE, while content is distributed across various digital channels to gradually advance customer beliefs.
4. The final result is omnichannel digital precision marketing with strong alignment between strategy and execution.
This full process is exactly the core of MeDomino's NICE solution.
NICE, or Next Intelligent Customer Experience, is a customer-journey-centered, digital-intelligence-driven growth tool that ensures consistency in strategy implementation.
It is a mature system proven in the life sciences industry, with rich implementation experience that helps pharma and medtech companies achieve comprehensive digital-intelligent transformation. Another article offers a more intuitive explanation of the NICE solution:
Customer-Centric Closed-Loop Precision Marketing Amid Major Changes in Speaker Fees
We know some friends could not attend because of schedule conflicts. That is all right. Let us look forward to meeting next time. The discussions will not stop. The show must go on.
